Risk stratification for ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Implantable cardioverter defibrillators (ICDs) reduce mortality in ischemic heart failure.
• The benefit of ICDs in nonischemic cardiomyopathy (NICM) is less clear.
• A need exists for risk stratification in NICM patients for primary prevention ICD implantation.

Purpose of the Study:

• To develop and validate a risk stratification score for ventricular tachyarrhythmia (VTA) in NICM patients.
• To identify key predictors of VTA and ICD therapies in this population.
• To aid in the selection of NICM patients for primary prevention ICDs.

Main Methods:

• Utilized data from 1515 NICM patients in the MADIT trials.
• Employed Fine and Gray competing risk analysis to predict VTA and ICD therapies.
• Validated the model externally in the RAID Trial population.

Main Results:

• Identified four risk factors for VTA: male sex, LVEF ≤25%, no CRT-D indication, and Black race.
• Stratified patients into low, intermediate, and high-risk groups with 5-year VTA incidences of 15%, 24%, and 42%.
• Achieved an AUC of 69.3 for appropriate ICD shock in the validation cohort.

Conclusions:

• Demographic and clinical variables can effectively risk stratify NICM patients for primary prevention ICDs.
• The developed score aids in evaluating NICM patients for ICD implantation.
• This risk stratification may optimize ICD utilization in nonischemic cardiomyopathy.